{"name":"Sio Gene Therapies","slug":"sio-gene-therapies","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNNzg2TG1VWW1CdXdkQUFuUzRVd0JGQ0x0OEMyQ2p6OWh1QjRnXy1fUXQzTFJyRkpWdEVaZ0t6R21qelJjVEpjRzdTMnU1S0M4dVphZ1o1aGhiVEx6ams2QjFVQ1ROSkV0RkwtU1c0SjVDZUJoZ1JLczFveEhXekxHOGtadF9IR193bVhMVFhiSThlNk9TaFl2TVYzcVA1ajFMbjFqbDRmTkJnMXVKUmh0YldiZVh6QkVWSnM3QUpCTmhYdEh3c3RMS2NlOWo4NzNQMkhaVmp6Q0Vmdnp6OUNsT2hONWh4ek5ZZDRIdWFXeDJKbm5kbjlNY05lMnhyTzRGRkRaeXlFZFM4MUtVbmg1M1BKWFc?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Ma","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-05","type":"trial","source":"globenewswire.com","summary":"AAV for the Hereditary Retinal Diseases Clinical Trial - globenewswire.com","headline":"AAV for the Hereditary Retinal Diseases Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE40XzhuVUxCNzNrVXRpalNwZ3NQNERFa2VsZUVmSXRJV3I4TmttTk55c014T09NUTdIY2w0bERpTktpMWJLOWZCU2pkVjM3a1pualJBb2ZfRk1CdnZheW1B?oc=5","date":"2025-05-16","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1TZE5uamNqeFpndTNvUEg2dDYyNHoxc2tpM2x2VlgzbWpBSkFia1ExRE9iZ052b3ZRZnd3Q1k0eDU1Y1lFRlFCeHBNRWI4dWZjWmtJ?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"SIOX Stock Price, News & Analysis - Stock Titan","headline":"SIOX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxORV9rNzJNLWJ2WWxXTktiM05GaUE3a3k2Z3dub2hlREZWUGdvVDBNT05Xbmh2U1lUWmFfMzFHaHhJY1Rhb2FmNWx6M3hwNW54YXQxeEZ3UFE1U1AyNy1JUVM4TTVLYVdEdGpkenJpaUZ1a2tyLUh6LWhMRGJjZVF5LUtVWmRPVTBVaXNKNXpTU2dNck5OaE1raVRYd1dwUXh4alRsemtURkZJc0VlUE1SdmpSYVpsZE16eXFuV3llaURzSVJ3MUtRYy1yYWFEaFJKZG42YndSbmhOV0U?oc=5","date":"2025-04-22","type":"pipeline","source":"PR Newswire","summary":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight - PR Newswire","headline":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQMnUzdGx1c0tfTkdyVk5lbG1BMGg4VnVzZDhsQWI1QklWNHRPYzRkdVZaQm1jc2gxcVh6VXUzc0xNNTdQeGVGV2EzUkdmVlFvVWlQcUpoRmY1S2FFZTUzckdBdmhTYWdtVU1rckt6bUVKYjRacFQwYUdLNS1SV0U2NXphdVRqMXlOMmNPREZ2bEgtOC1vdVE?oc=5","date":"2025-01-15","type":"pipeline","source":"Frontiers","summary":"Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics - Frontiers","headline":"Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNVkswS0hqdk4waDAwdEtqMnlrU2Y5SDB4UnZSYU5qSnZFWTBrNVFKOWZmUlVNbmd6OVY2b3hkUU5DRHA1Z3ZuMnJCMmFQbVdlVnlvUi1LMnFYUF9BR2pjdV9zZjFSejNZVWo4YTJzUmQ2cmszSTVEMkEtVjFMaVhmTFlERUYzT1d0aG5V?oc=5","date":"2022-12-16","type":"pipeline","source":"pharmaphorum","summary":"Sio Gene Therapies comes to the end of its rocky road - pharmaphorum","headline":"Sio Gene Therapies comes to the end of its rocky road","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOYWFZeG9NZ09NXzJDaGlFYXJNQ1RfSC0tWGVYM3c1b2J3YXhjMGFvUDIwMVg0UnI1NUR4UEcyM0I2UDhudGtBZlMzT0RtdUtRNERZRWJtSFlqNy1QWEhmYmR2YVhxRjB4R1VWWWhiaDlwNi1xSVAzSW5FUWh6YXI5Tl9rblg?oc=5","date":"2022-12-15","type":"pipeline","source":"BioPharma Dive","summary":"Sio Gene Therapies to dissolve after years of setbacks - BioPharma Dive","headline":"Sio Gene Therapies to dissolve after years of setbacks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdHFwb28tYnpLLURxMmhBd2h4VVZXZ1hvTlRxRXcteDE0VFRqWC01c1B4Z2NsampSZnVBbWp3dWl3c1ZjSHNIZVVFakFHamx1bW9vU0RnUVlSWjVDa1hSdEZXb09hbVhVeUZhbE5nV2YxYmpPcjVoZWxVa3NLQmg4dXUxQndfaUV0M0o2cC1MVTVKVW1CN0tHSS1GZG5uZzI2a0dTQUxNSHM3SlZDNGxGQVd3?oc=5","date":"2022-04-28","type":"pipeline","source":"Fierce Biotech","summary":"UPDATE: Sio Gene Therapies warns of 'significant' layoffs after ditching final 2 assets - Fierce Biotech","headline":"UPDATE: Sio Gene Therapies warns of 'significant' layoffs after ditching final 2 assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOVzdfMHBKbUozV1llcnZMWEozUVkxcnVEN29aNTVUcmlrWmtvTk9HanJ4V2IyWVQzUXZ2cVZtN2xqWElxb3A0QlhDMUR0RVZOdnl2QlZvejNxYnJER0szaVNLTFJvRWtaakZvZ2pqZ0ZZRUY4TWxQOTdiZTZxSjdhdTQ4NzZhY2s?oc=5","date":"2022-04-28","type":"pipeline","source":"BioPharma Dive","summary":"After setbacks, a gene therapy company mulls a sale - BioPharma Dive","headline":"After setbacks, a gene therapy company mulls a sale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPVHBfQi1LaWVGX0ROYkZqRm5YZjEzeEZWbTJYOVVVY0QyMHZMZml1WU1paXZ5YjdlSVZWWnl1MUFLWnEwZE5TRUFVbEhZTnFFcDNvS2JoOXFSbjZnVzRnc0JtUVR4QTZUQkgwMlhiT200M2NoTzVOZk5hLTUyYkhuNGQ2VDlGdHhOQkNETg?oc=5","date":"2020-12-07","type":"pipeline","source":"PharmaLive","summary":"Sio Gene Therapies promotes new chief commercial officer - PharmaLive","headline":"Sio Gene Therapies promotes new chief commercial officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQX1otNVlMeEdPMXZqRTM1Um1DTW81bGJTMExJTENta0NYVmozTURCeHRFZGtnR3Bqbjk4b0ZrZ1J5cWpIRGZNOUotSkZJNVpQekJDTXNqWmdFZ2lMejd1WVVKZXhseFJaWWlmdG1TbFBMR0FSa2loVmlMMzc1U2JjdlFUU2Rmd2VaenA2Z2kxakQxUC1hUl9kSC1adndYRXFBeGlBZy1QUFZvZ1lnckI2YkRHMVRtaW1sVW0w?oc=5","date":"2020-11-10","type":"pipeline","source":"BioSpace","summary":"Axovant Changes Name to Sio Gene Therapies, Adding to List of Biopharma Company Rebrands - BioSpace","headline":"Axovant Changes Name to Sio Gene Therapies, Adding to List of Biopharma Company Rebrands","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}